Predictors of Deterioration in Mental Well-Being and Quality of Life among Family Caregivers and Older People with Long-Term Care Needs during the COVID-19 Pandemic.

Publication date: Feb 01, 2024

During the COVID-19 pandemic, reduced access to care services and fear of infection prompted families to increase home care for their older relatives with long-term care needs. This had negative effects on both members of the caring dyad, impacting their quality of life (QoL) and mental well-being. This study investigated the factors that influenced the mental well-being and QoL of 239 dyads, before and after the first pandemic wave in Italy. Data were collected through a survey on the use of health and social care services and interventions by older care recipients living in the community and their family caregivers. Factors associated with deterioration of mental well-being and QoL in older care recipients (mean age 86. 1 years old) and their family caregivers after the pandemic were studied. The importance attached by family caregivers to the skills and training of healthcare professionals was a protective factor against the deterioration in the well-being of older care recipients. Similarly, the importance associated by family caregivers to the help received from healthcare professionals was a protective factor for QoL. Financial hardship of older care recipients was a risk factor for deterioration in caregivers’ mental well-being, while support from other family members was a protective factor for QoL. The presence of attentive healthcare professionals, a supportive family environment, and economic support can reduce the burden on both the caregiver and the older care recipient. These aspects need to be considered in any future emergency situation and when planning care services for community-dwelling older people.

Open Access PDF

Concepts Keywords
Caregivers COVID-19 pandemic
Economic informal caregivers
Italy long-term care
Old mental well-being
Pandemic older people
quality of life


Type Source Name
disease IDO quality
disease MESH COVID-19 Pandemic
disease MESH infection
disease MESH emergency
disease VO population
disease MESH chronic conditions
drug DRUGBANK Coenzyme M
disease MESH dementia
disease MESH cognitive decline
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH loneliness
disease MESH insomnia
disease VO Gap
disease VO effectiveness
drug DRUGBANK Etoperidone
drug DRUGBANK Methylergometrine
disease MESH care burden
drug DRUGBANK Isoxaflutole
disease VO USA
drug DRUGBANK Methionine
disease VO frequency

Original Article

(Visited 1 times, 1 visits today)